Sandra Schwarz

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Peripheral Blood

Top Venues

NPJ precision oncology

Signal transduction and targeted therapy

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Schwarz, Zhaoran Su, Mathias Krohn, Markus W Löffler, Andreas Schlosser, Michael Linnebacher
Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells. NPJ precision oncology 8 (1) (2024)
Sandra Schwarz, Zhaoran Su, Mathias Krohn, Markus W Löffler, Andreas Schlosser, Michael Linnebacher
Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells. NPJ precision oncology 8 (1) (2024)
Sandra Schwarz, Zhaoran Su, Mathias Krohn, Markus W Löffler, Andreas Schlosser, Michael Linnebacher
Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells. NPJ precision oncology 8 (1) (2024)
Sandra Schwarz, Michael Linnebacher
CD5: from antiquated T cell marker to immunotherapy's new hope. Signal transduction and targeted therapy 8 (1) (2023)
Sandra Schwarz, Johanna Schmitz, Markus W Löffler, Michael Ghosh, Hans-Georg Rammensee, Evgenia Olshvang, Marvin Markel, Nadine Mockel-Tenbrinck, Andrzej Dzionek, Susann Krake, Basak Arslan, Kapil Dev Kampe, Anne Wendt, Peter Bauer, Christina S Mullins, Andreas Schlosser, Michael Linnebacher
T cells of colorectal cancer patients' stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells. Journal for immunotherapy of cancer 10 (12) (2022)